Kangstem Biotech Co. Ltd (217730) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.087x

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has a cash flow conversion efficiency ratio of -0.087x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.93 Billion ≈ $-3.34 Million USD) by net assets (₩56.56 Billion ≈ $38.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Kangstem Biotech Co. Ltd worth for the company's overall valuation and market capitalisation.

Kangstem Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Kangstem Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kangstem Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Kangstem Biotech Co. Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sungshin Cemen KO:004980	0.018x
Greystone Housing Impact Investors LP NYSE:GHI	0.000x
NIIT Limited NSE:NIITLTD	-0.015x
Wam Alternative Assets Ltd AU:WMA	-0.150x
Diamond Building Products Public Company Limited BK:DRT	0.054x
AirBoss of America Corp. TO:BOS	0.015x
UNIBEP S.A. WAR:UNI	0.584x
Davicom Semiconductor Inc TW:3094	0.005x

Annual Cash Flow Conversion Efficiency for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2025. View Kangstem Biotech Co. Ltd (217730) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩69.06 Billion ≈ $46.80 Million	₩-11.68 Billion ≈ $-7.91 Million	-0.169x	+61.55%
2024-12-31	₩43.18 Billion ≈ $29.26 Million	₩-18.99 Billion ≈ $-12.87 Million	-0.440x	-18.65%
2023-12-31	₩44.52 Billion ≈ $30.17 Million	₩-16.50 Billion ≈ $-11.18 Million	-0.371x	+7.15%
2022-12-31	₩47.26 Billion ≈ $32.03 Million	₩-18.86 Billion ≈ $-12.78 Million	-0.399x	-59.89%
2021-12-31	₩68.07 Billion ≈ $46.13 Million	₩-16.99 Billion ≈ $-11.52 Million	-0.250x	+7.92%
2020-12-31	₩51.62 Billion ≈ $34.98 Million	₩-13.99 Billion ≈ $-9.48 Million	-0.271x	-43.92%
2019-12-31	₩70.72 Billion ≈ $47.93 Million	₩-13.32 Billion ≈ $-9.03 Million	-0.188x	+21.73%
2018-12-31	₩47.69 Billion ≈ $32.32 Million	₩-11.48 Billion ≈ $-7.78 Million	-0.241x	+46.94%
2017-12-31	₩23.47 Billion ≈ $15.91 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.454x	-33.67%
2016-12-31	₩22.98 Billion ≈ $15.57 Million	₩-7.80 Billion ≈ $-5.28 Million	-0.339x	-89.64%
2015-12-31	₩21.24 Billion ≈ $14.39 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.179x	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$135.45 Million

₩199.87 Billion KRW

Market Cap Rank

#18131 Global

#793 in Korea

Share Price

₩2125.00

Change (1 day)

-0.70%

52-Week Range

₩1397.00 - ₩4615.00

All Time High

₩18836.30